Results 1 to 10 of about 57,757 (199)

Guillain–Barré Syndrome Associated with COVID-19 in a Japanese Male

Case Reports in Neurological Medicine, 2022
April 2021 saw a widespread outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Osaka, Japan. We encountered the case of a 52-year-old man who had Guillain–Barré syndrome associated with coronavirus disease 2019 (COVID-19).
Yoshiki Esa, Yuta Kajiyama, Misako Kaido, Yushi Watanabe, Harutoshi Fujimura, Iwao Gohma, Kenichi Takahashi, Junya Kobayashi   +7 more
doaj   +1 more source

Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

Journal of Nobel Medical College, 2021
Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the ...
Sushmita Khanal, Sunil Babu Khanal
doaj   +1 more source

Anestesia em criança com síndrome de Guillain-Barré após vacina de sarampo: relato de caso Anestesia en un niño con síndrome de Guillain-Barré después de la vacuna de sarampión: relato de caso Anesthesia in Guillain-Barré pediatric patient after measles vaccination: case report

Revista Brasileira de Anestesiologia, 2005
JUSTIFICATIVA E OBJETIVOS: A síndrome de Guillain-Barré após vacina de sarampo é rara. O diagnóstico muitas vezes é tardio, o que leva a um aumento da morbidade.
Deoclécio Tonelli, Paula de Camargo Neves Sacco, Desire Calegari, Gustavo Cimerman, Carolina Mourão dos Santos, Rodrigo Gonzales Farath   +5 more
doaj   +1 more source

Guillain-Barré syndrome following COVID-19: new infection, old complication?

Journal of Neurology, 2020
The coronavirus disease-2019 (COVID-19) pandemic originated in Wuhan (China) on December 2019. So far, more than 1,500,000 cases have been confirmed worldwide (> 150,000 cases in Italy) [1].
M. Padroni, V. Mastrangelo, G. Asioli, Lucia Pavolucci, Samir Abu-Rumeileh, M. Piscaglia, Pietro Querzani, C. Callegarini, M. Foschi   +8 more
semanticscholar   +1 more source

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

Lancet Neurology, 2021
BACKGROUND Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barré syndrome.
C. Walgaard, B. Jacobs, Hester F. Lingsma, E. Steyerberg, B. Berg, A. Y. Doets, S. Leonhard, C. Verboon, R. Huizinga, J. Drenthen, S. Arends, I. K. Budde, R. P. Kleyweg, K. Kuitwaard, M. F. V. D. Meulen, J. Samijn, F. Vermeij, J. Kuks, G. W. Dijk, P. Wirtz, F. Eftimov, A. J. Kooi, M. Garssen, C. J. Gijsbers, M. D. Rijk, L. Visser, Roderik J. Blom, W. Linssen, E. L. Kooi, J. Verschuuren, R. V. Koningsveld, R. Dieks, H. Gilhuis, K. Jellema, T. Ree, H. Bienfait, C. Faber, Harry Lovenich, B. Engelen, R. J. Groen, I. Merkies, B. W. Oosten, W. L. Pol, W. D. V. D. Meulen, U. Badrising, M. Stevens, A. J. Breukelman, C. Zwetsloot, M. V. D. Graaff, M. Wohlgemuth, R. Hughes, D. Cornblath, P. Doorn, B. Jacobs, Hester F. Lingsma, E. Steyerberg, B. Berg, A. Y. Doets, S. Leonhard, R. P. Kleyweg, M. F. V. D. Meulen, J. Samijn, F. Vermeij, J. Kuks, G. W. Dijk, P. Wirtz, A. J. Kooi, M. Garssen, C. J. Gijsbers, M. D. Rijk, L. Visser, Roderik J. Blom, W. Linssen, E. L. Kooi, J. Verschuuren, R. V. Koningsveld, R. Dieks, H. Gilhuis, T. Ree, H. Bienfait, Karin G. Faber, B. Engelen, R. J. Groen, I. Merkies, B. W. Oosten, W. L. Pol, W. D. V. D. Meulen, U. Badrising, A. J. Breukelman, C. Zwetsloot, M. V. D. Graaff, R. Hughes, D. Cornblath, P. Doorn, R. B. A. V. Geusau, C. V. Boheemen, I. Bronner, B. Feenstra, C. Fokke, T. Hoogendoorn, R. V. Houten, A. Hovestad, P. Jansen, E. Keuter, J. Krudde, F. Linn, J. Lion, S. Manschot, S. Mellema, D. Molenaar, D. Nieuwkamp, D. Oenema, J. Oostrom, N. P. Orshoven, R. V. D. Ploeg, S. Polman, A. Ruitenberg, L. Ruts, Angelique Schyns-Soeterboek, R. Trip   +119 more
semanticscholar   +1 more source

Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?

Clinical neurology and neurosurgery (Dutch-Flemish ed. Print), 2021
We report a case of Guillain-Barré syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset. As the COVID-19 vaccination campaign progresses worldwide, GBSs vaccine-related have been increasingly ...
Alessandro Introna, F. Caputo, C. Santoro, T. Guerra, M. Ucci, Domenico Maria Mezzapesa, M. Trojano   +6 more
semanticscholar   +1 more source

Guillain-Barré Syndrome Associated with COVID-19 Vaccination

Emerging Infectious Diseases, 2021
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain-Barré syndrome after coronavirus disease vaccination.
S. Shao, Chien-Ho Wang, Kai-Cheng Chang, M. Hung, Hui-Yu Chen, S. Liao   +5 more
semanticscholar   +1 more source

Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital

Neurological Sciences, 2020
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune processes, often related to a previous infectious exposure.
D. Ottaviani, F. Boso, E. Tranquillini, Ilaria Gapeni, G. Pedrotti, S. Cozzio, G. Guarrera, B. Giometto   +7 more
semanticscholar   +1 more source

Severe Hyponatremia as the Initial Sign Preceding Guillain-Barré Syndrome, an Acute Inflammatory Demyelinating Polyneuropathy: A Case Report

Case Reports in Neurological Medicine, 2013
Guillain-Barré syndrome is an immune-mediated polyneuropathy that frequently presents with progressive muscle weakness. Hyponatremia has recently been described as a feature of this condition, generally appearing over the course of the illness and ...
Benjamin Kloesel, LaTonya J. Hickson
doaj   +1 more source

A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant

The Turkish Journal of Pediatrics, 2008
Guillain-Barré syndrome is clinically characterized by acute onset of generalized, symmetrical, and ascending muscle weakness and areflexia from peripheral nerve involvement. In Guillain-Barré syndrome variants, however, some patients have unusual
M Ozlem Hergüner, Tugay Tepe, Sakir Altunbaşak, Vildan Baytok   +3 more
doaj